Latest News On Drug Costs

Latest KFF Health News Stories

Bill Of The Month: For Toenail Fungus, A $1,500 Prescription

KFF Health News Original

How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.

Podcast: KHN’s ‘What The Health?’ HHS Leaders Take To The Stump

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

KFF Health News Original

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

Para abaratar el costo de los medicamentos, estados quieren importarlos de Canadá

KFF Health News Original

Algunos estados buscan impulsar al gobierno federal para que allane el camino para comprar stocks de medicamentos en Canadá con el fin de abaratar los costos y ahorrarle dinero a las arcas estatales.

KHN On NPR: The Uniquely American Problem Of High Prescription Drug Costs

KFF Health News Original

Kaiser Health News Editor-in-Chief Elisabeth Rosenthal discusses drug costs with Scott Simon, the host of NPR’s Weekend Edition. Listen to the broadcast and read a transcript of that conversation.

Podcast: KHN’s ‘What The Health?’ There’s A Really Big Health Bill In That Budget Deal

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”

Podcast: KHN’s ‘What The Health?’ The State Of The (Health) Union

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.

Expert Advice For The Corporate Titans Taking On Health Care

KFF Health News Original

Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?

Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?

KFF Health News Original

In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.